Neurodevelopmental Implications of Fetal Exposure to Selective Serotonin Reuptake Inhibitors and Untreated Maternal Depression: Weighing Relative Risks

Lee S Cohen, Ruta Nonacs

JAMA Psychiatry 2016 November 1, 73 (11): 1170-1172

No abstract text is available yet for this article.

Full Text Links

Find Full Text Links for this Article

Additional links

You are not logged in. Sign Up or Log In to join the discussion.

Selective serotonin reuptake inhibitors for depression in pregnancy. Leah C Susser, Stephanie A Sansone, Alison D Hermann American Journal of Obstetrics and Gynecology 2016, 215 (6): 722-730

The use of antidepressants in pregnancy: focus on maternal risks. Yifat Gadot, Gideon Koren Journal of Obstetrics and Gynaecology Canada: JOGC 2015, 37 (1): 56-63

Selective serotonin reuptake inhibitors and pregnancy: A review of maternal, fetal and neonatal risks and benefits. Zbigniew Marchocki, Noirin E Russell, Keelin O' Donoghue Obstetric Medicine 2013, 6 (4): 155-8

The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring. J D A Olivier, H Akerud, H Kaihola, J L Pawluski, A Skalkidou, U Högberg, I Sundström-Poromaa Frontiers in Cellular Neuroscience 2013, 7: 73

Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Irena Nulman, Gideon Koren, Joanne Rovet, Maru Barrera, Ariel Pulver, David Streiner, Brian Feldman American Journal of Psychiatry 2012, 169 (11): 1165-74

Antenatal use of selective serotonin-reuptake inhibitors and QT interval prolongation in newborns. Gal Dubnov-Raz, David N Juurlink, Rami Fogelman, Paul Merlob, Shinya Ito, Gideon Koren, Yaron Finkelstein Pediatrics 2008, 122 (3): e710-5

Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Hanan El Marroun, Vincent W V Jaddoe, James J Hudziak, Sabine J Roza, Eric A P Steegers, Albert Hofman, Frank C Verhulst, Tonya J H White, Bruno H C Stricker, Henning Tiemeier Archives of General Psychiatry 2012, 69 (7): 706-14

WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). C Barbui, M Hotopf, N Freemantle, J Boynton, R Churchill, M P Eccles, J R Geddes, R Hardy, G Lewis, J M Mason Cochrane Database of Systematic Reviews 2006, (3): CD002791

Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence. C Barbui, M Hotopf, N Freemantle, J Boynton, R Churchill, M P Eccles, J R Geddes, R Hardy, G Lewis, J M Mason Cochrane Database of Systematic Reviews 2000, (4): CD002791

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Read